Type / Class
Equity / Common Stock, par value $0.004 per share ("Shares")
Shares outstanding
22,866,677
Number of holders
96
Total 13F shares, excl. options
41,890,221
Shares change
+1,353,182
Total reported value, excl. options
$586,472,317
Value change
-$21,543,705
Put/Call ratio
424%
Number of buys
40
Number of sells
58
Price
$14.00

Institutional Holders of BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) as of Q4 2024

As of 31 Dec 2024 BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) had 123 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 41,890,221 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, Point72 Asset Management, L.P., FCPM III SERVICES B.V., WESTFIELD CAPITAL MANAGEMENT CO LP, ARMISTICE CAPITAL, LLC, Siren, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, Deep Track Capital, LP, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, and BNP PARIBAS ASSET MANAGEMENT Holding S.A..
This table shows 123 institutional shareholders of the security as of 31 Dec 2024.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.